RE: Innova £1.2 billion contract win10 Apr 2021 17:50
Avactas comments on the tie up with Mologic. A LOW RISK route to CE marking in Q1. This then slipped to around the end of Q1 in the business update. I can understand folks frustrations at seeing this innova deal.
Dr Alastair Smith, Chief Executive Officer of Avacta Group, commented:
“I am very pleased to announce this partnership with Mologic, which follows a close collaboration over recent months. The partnership provides Avacta with a low risk route to CE marking our rapid antigen test during Q1 ahead of achieving our own ISO13485 accreditation.